skip to content

ReNeuron Group

13:55 on 23/11/2017

Current Price 1.97p | Bid 1.95p | Ask 2.00p | Change -1.25%

Company Overview

ReNeuron Group plc s a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered 'off-the-shelf' to any eligible patient without the need for additional immunosuppressive drug treatments. ReNeuron's lead candidate is its ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. This therapy is currently in clinical development. The Company is also developing stem cell therapies for other conditions such as peripheral arterial disease, a serious and common side-effect of diabetes, and blindness-causing diseases of the retina. ReNeuron has also developed a range of stem cell lines for non-therapeutic applications - its ReNcell®products for use in academic and commercial research. The Company's ReNcell®CX and ReNcell®VM neural cell lines are marketed worldwide under license by USA-based Merck Millipore.

Stock Details

Shares in Issue 3,159,256,868
Market cap £ 86.88m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Financial Highlights Year Ended 31/03/2014

Turnover £0.02 million
Operating Profit £-7.97 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -6.88
» More Financials

Key Personnel

Michael Hunt CEO

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 1.98p
Bid Price ? 1.95p
Ask Price ? 2.00p
Volume ? 247050
Change Today -0.03p
% Change Today -1.25%
Open 2.00p
Previous Close 2.00p
Intraday High 2.00p
Intraday Low 1.97p
52 Week High 5.38p
52 Week Low 2.38p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Aberdeen Ediston

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.